Atlas Trials

Comparison of the FGM Profiles in Patients of Type 2 Diabetes Treated With Sitagliptin and Acarbose

Clinical trial NCT05035849 · COMPLETED

Trial details

NCT number
NCT05035849
Sponsor
Nanjing First Hospital, Nanjing Medical University
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Type 2 Diabetes
Start date
2020-01-30
Primary completion
2021-04-30
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.